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Many research areas, particularly those focused on structural aspects of biomolecules, have “moved
into cyberspace” in the last 20–30 years. This move has become even more prominent in the last
5–10 years, amplified by the increased space accessibility (from mobile devices to the Cloud) and
by ever more sophisticated and powerful resources available for high-performance computing. The
field of structural glycobiology has greatly benefitted from such progress and has taken advantage
of the computational tools and resources developed specifically for the structural analysis of
carbohydrates. In this short opinion piece, we do not intend to provide a comprehensive coverage
of all such resources. We will briefly survey four websites [GLYCAM, UniCarb KnowledgeBase
(UniCarbKB), Glycosciences.de, and Glyco3D], offering tools for structural glycobiology, and will
provide some examples of studies where such tools have been successfully used for research relevant
to understanding of carbohydrate recognition by proteins involved in immunity and infection. For a
more comprehensive listing of computational resources for structural glycobiology, readers should
consult Ref. (1–4).
GLYCAM-Web (5) is focused on the prediction of three-dimensional (3D) structures of car-
bohydrates and macromolecular structures that include carbohydrates. The server is created and
operated by the research group of Prof. Robert J. Woods in the Complex Carbohydrate Research
Center (CCRC) (6) at the University of Georgia in Athens. The server can perform conformational
modeling of oligosaccharides as well as 3D modeling of glycoproteins. The main interfaces for
modeling oligosaccharide conformations are the Carbohydrate Builder [including a special Builder
for glycosaminoglycans (GAGs)], the Glycoprotein Builder, and the Oligosaccharide Libraries. The
server is user-friendly and allows a range of upload and download options. Given a range of
file formats – often, program-specific – used in molecular modeling, user-friendliness related to
the portability of file formats is a significant “real-estate” feature highly valued by the cyberspace
dwellers.
Most of the back-end software used by the server is open source and freely available to the public.
This feature is also highly valued by viewers. The reason is not only reduced cost but also the
openness of science that could be performed with open-source software. We consider such open
access as critical in the field of molecular modeling: it allows researchers to use the program codes
and develop them further, thus advancing the development of better modeling methods.
Themain engine roomof the server is theGLYCAM force field, the outcome ofmore than 20 years
of development. Its latest incarnation, GLYCAM06 (7), has been significantly modified to satisfy the
following requirements: transferability of the parameter set to all carbohydrate ring conformations
and sizes, carbohydrate derivatives, and other biomolecules; self-containment and transferability to
many quadratic force fields; ability to treat both α- and β-anomers without specific atom types.
The GLYCAM-Web server (5) is a very widely and extensively used resource. Its statistics records
show that an average of 1700–1800 unique users access the site monthly (data examined: December
2014–March 2015).
The GLYCAM-Web server (5) and the GLYCAM force field (7) were used for the investigation of
recognition specificity of ABO blood group antigens by antibodies (8). Such circulating antibodies
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could cause a hyperacute immune response and sometimes death
resulting frommismatched blood transfusion or organ transplan-
tation (9). Another recent example of application of GLYCAM
was in the study of structure and immune recognition of HIV-1
envelope (10), where it was used formodeling theN-linked glycan
shield.
UniCarb KnowledgeBase (11, 12) was conceived to support
online data storage and search capabilities for glycomics and
glycobiology by integrating structural, experimental, and func-
tional information. The aim of UniCarbKB is to advance the
understanding of structures, pathways, and networks involved
in glycosylation and processes mediated by carbohydrates. This
information-rich resource is freely accessible, supports data anno-
tation, and promotes adoption of common standards, necessary
for seamless and meaningful integration of structural and func-
tional data. UniCarbKB is the outcome of the collaborative effort
of researchers from Australia (Macquarie University and Univer-
sity of NSW), Germany (Max Planck Institute of Colloids and
Interfaces), Ireland (National Institute for Bioprocessing Research
and Training), Japan (Soka University), Sweden (University of
Gothenburg), Switzerland (Swiss Institute for Bioinformatics and
University of Geneva), and USA (CCRC).
UniCarb KnowledgeBase provides querying interfaces for
three-structural databases (GlycoSuiteDB, EUROCarbDB, and
GlycoBase) and a link to the UniCarb-DB (13). UniCarbKB
continues efforts started with GlycoSuiteDB (14) in curating
structural glycobiology information from research literature. Gly-
coBase (15) and UniCarb-DB (16) are databases of experimental
glycan structures. Support for EUROCarbDB (17) is planned for
the future release.
At the time of writing, over 906 references, 3238 glycan struc-
ture entries, and 898 glycoproteins have been curated in Uni-
CarbKB. A total of 598 protein glycosylation sites have been
annotated using experimentally confirmed glycan structures.
Beyond storing, curating, and providing searchable access to
structural and functional data, UniCarbKB offers a range of
tools for data pre-process and analysis: GlycanBuilder (18, 19) –
for fast and intuitive drawing of glycan structures; GlycoMod
tool (20, 21) – for predicting the possible glycan structures on
proteins, from their experimentally determined masses. Uni-
CarbKB is connected to the GLYCAM site (described above)
and RINGS – a web resource offering algorithms and data
mining tools for glycobiology research (22). Further, through
its SugarBindDB module, UniCarbKB is linked to the Func-
tional Glycomics Gateway of the Consortium for Functional
Glycomics (CFG) (23) and the Glyco3D Portal for Structural
Glycosciences (24, 25).
The GlycoMod tool of the UniCarbKB was used in a study
of the formation of subcellular-specific N-glycosylation glyco-
protein determinants (26). Lee et al. used liquid chromatog-
raphy and mass spectrometry-based quantitative glycomics to
investigate eight human breast epithelial cells with diverse geno-
types and phenotypes – mostly human breast cancer cell lines –
and have shown that the secreted glycoproteins consistently
displayed more processed, primarily complex type, N-glycans
than the high-mannose-rich microsomal glycoproteins. They
have also demonstrated that secreted glycoproteins displayed
significantly more α-sialylation and α-1,6-fucosylation, but
less α-mannosylation, than both cell-surface and microsomal
glycoproteomes.
Of particular interest to those working on the glycobiology of
infectious disease is the SugarBindDB module of UniCarbKB –
a database of pathogen lectins and corresponding glycan tar-
gets (27, 28). The SugarBindDB advances a pathogen-capture
technology specifically for the binding of pathogen lectins to
carbohydrate epitopes. The contents of the database come from
publicly accessible information. After experts (glycobiologists,
microbiologists, andmedical histologists) locate candidate papers,
the binding data is extracted for human pathogens and specific
glycans.
The SugarBindDB database can be searched using names of dif-
ferent entities involved in the carbohydrate-protein interactions.
For pathogenic agents (e.g., Pseudomonas aeruginosa), the out-
comes include agent type and taxonomy ID. For lectins themselves
(e.g., PA-IIL), the database stores genes, Protein Data Bank (PDB)
codes, and associated Glyco3D and CFG references (see below for
more information about the Glyco3D resources). A query could
also be constructed for specific ligands (e.g., Lewis X). The entries
in SugarBindDB are limited to sugar sequences that demonstrate
consistent binding to pathogen lectins. Sugar sequences include
“glycotope” within a larger carbohydrate structure (the precise
lectin-binding site) or entire structures, depending on specific
findings within the cited papers. Similar to the GLYCAM-Web
server mentioned above, the SugarBindDB is user-friendly in
that it allows displaying glycans in a variety of formats; specif-
ically, it supports the modified 2D condensed IUPAC nomen-
clature, Oxford symbol notation, and the colored CFG cartoons.
A sugar query can be input as a structure drawn with Gly-
canBuilder (18, 19). The SugarBindDB database can also be
browsed by disease (e.g., Influenza) or by published references
(by author or title descriptions) or searched by the affected area
in the pathology (e.g., intestine). Search outputs are very infor-
matively interconnected, i.e., the biological context of each ligand
is shown in relation to a disease, to other known ligands, to
similar lectins, etc. At the time of writing, over 178 references,
549 pathogenic agents, and 200 ligands have been curated in
SugarBindDB.
Glyco3D (25) was developed at the Centre de Recherches sur
les Macromolécules Végétales (CERMAV-CNRS), France. It com-
prises a group of databases containing the 3D data collected from
an extensive screening of scientific literature: BiOligo (more than
250 bioactive oligosaccharides along with about 120 of their con-
stituting disaccharide and about 80 monosaccharide segments);
PolySac3DB (157 polysaccharides); Lectin3D (more than 1,000
structures); GAG3D (GAG-binding proteins co-crystallized with
their ligands); MAbs (a limited set of high resolution structures of
carbohydrate–antibody complexes); GT3D (glycosyltransferases
crystallized with or without their carbohydrate ligands). Lectins
are oligomeric proteins, which can specifically recognize carbo-
hydrates and are involved in many processes crucial to infection
and immunity (29); ~70% of the Lectin3D structures are present
in complex with a carbohydrate ligand, from monosaccharides
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to oligosaccharides or glycoproteins, allowing great insight into
the molecular basis of carbohydrate recognition by lectins. GAGs
are complex anionic polysaccharides (e.g., heparin), specifi-
cally recognized by protein receptors, which participate in the
regulation of many processes, including cell adhesion. Anti-
carbohydrate antibodies, demonstrating specificity to various car-
bohydrate epitopes, are of a high importance in immunology and
vaccine development (30).
The individual databases within Glyco3D are publically acces-
sible via the portal (24), furnished with a user-friendly graphi-
cal user interface with several search options. All 3D structures,
established using a variety of structure determination methods,
can be visualized and some basic measurements are possible
on the spot. For a more detailed analysis, the structures can
be downloaded in a variety of commonly used molecular file
formats.
Why would a user access 3D structural information relevant
to glycobiology via databases such as Glyco3D while it can be
obtained from the original sources, mainly PDB (31)? The answer
is: in databases, such as Glyco3D, the data is manually curated
and value-added. Such curation and value-adding is indispens-
able, given poor quality of structural information for carbohy-
drates in PDB. Agirre et al. have recently demonstrated that 64%
of all N-glycan -pyranosides in PDB reflect poor fit to the
electron density (32). They have revealed significant structural
errors, such as incorrect conformations, stereochemical config-
urations, and linkages, resulting from incorrect model building
from the start, as well as more subtle errors, resulting from
incorrect refinement. Even subtle errors could be detrimental if
incorrect structures are interpreted in a biological context. The
reasons for errors are various, but the main one seems to be
poor chemical understanding on the part of crystallographers
and the lack of appropriate torsional restraints, often in dis-
agreement with the low-resolution data. The detriment of such
errors goes beyond incorrect interpretations in specific cases. It
also leads to skewed statistics based on all published/deposited
structures, creating new abnormal “norms.” Thus, structural
glycobiology is now ripe for remediation of the type that
the protein crystallography field underwent in not too distant
past (33).
Tools for structural validation of carbohydrate 3D struc-
tural data are available, have been developed specifically for
carbohydrates, and are publically accessible (34). For example,
pdb-care (35) can check residue notation (which can be a source
of confusion for carbohydrate residues) and atom connectivities
and evaluate biological correctness of glycan structures. CARP
(carbohydrate Ramachandran plot) (36) analyses carbohydrate
data by generating a separate Phi/Psi plot for each linkage type,
such as in the study of conformational preferences of Shigella
flexneriO-antigens and their implications for vaccine design (37).
Information necessary for such plots can be obtained from the
GlyTorsion database (36), containing glycosidic torsions observed
in PDB entries, or from conformational maps based on molecular
dynamics simulations provided by GlycoMapsDB (38). Both pdb-
care and CARP are available at the Glycosciences.de portal (39).
To summarize, the online resources available for structural
glycobiology reviewed here demonstrate good scientific citizen-
ship features: multinational collaborative approach to design and
development, open access to data and code, and the drive for
common and accepted standards. The collaborative approach is
illustrated not only by initiatives such as UniCarbKB, but also
by efforts to cross-link and integrate existing resources (e.g.,
SugarBindDB and Glyco3D) and map functional and structural
information (e.g., mapping of SugarBindDB to GlycoSuiteDB to
link saccharide sequences with their physical location in the
body). Further, somewhat altruistic, aspect of these develop-
ments is the extensive effort that goes into manual curation of
data. Efforts like these should be recognized, credited, and sup-
ported more strongly by relevant scientific societies and funding
bodies.
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